Rapid Micro Biosystems, Inc.
RPID
$3.58
$0.102.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.36% | 24.57% | 27.31% | 29.04% | 28.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.36% | 24.57% | 27.31% | 29.04% | 28.25% |
| Cost of Revenue | -1.72% | 0.56% | -3.65% | 0.00% | 7.19% |
| Gross Profit | 134.84% | 98.01% | 84.05% | 61.28% | 37.93% |
| SG&A Expenses | -6.69% | -7.96% | -11.55% | -12.77% | -11.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.67% | -1.41% | -5.04% | -4.96% | -2.40% |
| Operating Income | 15.47% | 11.75% | 15.83% | 15.14% | 11.16% |
| Income Before Tax | 13.63% | 10.62% | 16.21% | 16.87% | 14.05% |
| Income Tax Expenses | -3.70% | -29.03% | 30.00% | 33.33% | 104.56% |
| Earnings from Continuing Operations | 13.63% | 10.63% | 16.19% | 16.85% | 13.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.63% | 10.63% | 16.19% | 16.85% | 13.15% |
| EBIT | 15.47% | 11.75% | 15.83% | 15.14% | 11.16% |
| EBITDA | 16.58% | 12.65% | 16.80% | 16.14% | 11.86% |
| EPS Basic | 14.87% | 11.74% | 17.23% | 17.88% | 14.21% |
| Normalized Basic EPS | 14.86% | 11.71% | 17.26% | 17.78% | 14.96% |
| EPS Diluted | 14.87% | 11.74% | 17.23% | 17.88% | 14.21% |
| Normalized Diluted EPS | 14.86% | 11.71% | 17.26% | 17.78% | 14.96% |
| Average Basic Shares Outstanding | 1.46% | 1.28% | 1.23% | 1.22% | 1.23% |
| Average Diluted Shares Outstanding | 1.46% | 1.28% | 1.23% | 1.22% | 1.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |